新冠病毒检测套组市场规模、份额及成长分析（依产品类型、检体/样本类型、最终用户、检测方法及地区划分）－2026-2033年产业预测

预计到 2024 年，全球 COVID-19检测套组市场规模将达到 861.9 亿美元，到 2025 年将增长至 927.4 亿美元，到 2033 年将增长至 1666.3 亿美元，预测期（2026-2033 年）的复合年增长率为 7.6%。

儘管大规模检测力度下降，但持续的公共卫生监测和感染族群对检测的持续需求仍然是全球新冠病毒检测套组市场的主要驱动力。在都市区，数位医疗解决方案和电子商务的普及使得居家检测更加便捷，从而推动了自测检测套组的广泛应用。鼻拭子和唾液检测因其便利性而备受青睐。能够同时检测多种呼吸道病毒的多重诊断技术投资正在蓬勃发展，吸引了寻求经济高效解决方案的卫生部门的关注。此外，人工智慧驱动的技术能够加快侦测速度，提高使用者对侦测结果的信心，无论是在家中或在检查室进行检测。儘管市场成长前景可期，但市场饱和和成本压力等挑战依然存在，这使得检测套组产业的发展道路充满挑战，但也充满希望。

全球新冠病毒检测套组市场驱动因素

全球新冠病毒检测套组市场的主要驱动因素是对感染疾病早期检测和快速反应的日益重视。随着世界各国公共卫生机构和政府将控制和预防新冠病毒传播的策略置于优先地位，对可靠检测解决方案的需求不断增长。人们对无症状感染的认识不断提高，以及对准确快速诊断的需求，推动了包括PCR检测和抗原检测在内的各种检测方法的应用。此外，不断提高检测准确性和速度的技术进步也在持续推动创新和市场成长，以满足医疗机构和公众的需求。

全球新冠病毒检测套组市场面临的限制因素

全球新冠病毒检测套组市场的主要限制因素之一是现有检测方案的饱和，加剧了製造商之间的竞争。居家检测和就地检验方案的快速普及导致市场碎片化，可能引发价格战并降低企业的利润率。此外，不断变化的监管环境和各地区的核准流程差异也使得新产品难以持续进入市场。而且，随着疫苗接种率的提高，大众对检测的疲劳感和需求的下降可能会进一步限制该领域製造商的成长机会，因此产品创新和多元化至关重要。

全球新冠病毒检测套组市场趋势

全球新冠病毒检测套组市场正经历着向自我检测和居家诊断的重大转变，这主要受分散式医疗解决方案需求的驱动。尤其是在疫情反覆爆发的情况下，基于唾液的抗原检测套组因其易用性而日益受到消费者的青睐，它们提供了一种无需临床环境即可进行的经济便捷的检测方法。监管核准的加强也推动了这一趋势，促进了居家检测解决方案的广泛应用。这一趋势不仅增强了消费者在健康管理方面的自主权，也反映了医疗服务模式的更广泛变革，并正在塑造诊断检测的未来。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术评估
• 监管环境
• 客户和购买标准分析
• 原料分析

全球新冠病毒检测套组市场规模（按产品类型和复合年增长率划分）（2026-2033 年）

• RT-PCR检测试剂盒
• 免疫检测测定试纸/试剂盒
• 基于CRISPR的分子诊断试剂盒
• 其他分子检测试剂盒

全球新冠病毒检测套组市场规模（依检体/样本类型划分）及复合年增长率（2026-2033 年）

• 鼻咽拭子
• 口咽拭子
• 鼻拭子
• 唾液样本
• 血液/指尖血液采样

全球新冠病毒检测套组市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院和诊所
• 诊断检查室
• 居家照护/自我检测
• 公共卫生机构
• 其他的

全球新冠病毒检测套组市场规模（依检测方法划分）及复合年增长率（2026-2033 年）

• 集中式检查室检测（非即时检测）
• 照护现场侦测 (POC)
• 店面销售（OTC）自测检测套组

全球新冠病毒检测套组市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Abbott Laboratories
• Thermo Fisher Scientific
• Roche Diagnostics
• BGI Group
• Qiagen
• Quidel Corporation
• Mylab Discovery Solutions
• SD Biosensor
• BioMerieux SA
• Danaher Corporation
• Hologic Inc.
• Seegene Inc.
• PerkinElmer Inc.
• Randox Laboratories
• CEPI（Collaborative entities）
• Guangzhou Wondfo Biotech
• Shenzhen Bioeasy Biotechnology
• Cepheid Inc.
• 1drop Inc.
• ADT Biotech

结论与建议

Global COVID Testing Kit Market size was valued at USD 86.19 Billion in 2024 and is poised to grow from USD 92.74 Billion in 2025 to USD 166.63 Billion by 2033, growing at a CAGR of 7.6% during the forecast period (2026-2033).

The global market for COVID testing kits is currently shaped by ongoing public health monitoring and the sustained demand for testing among affected populations, despite a decline in mass screening initiatives. Urban centers have embraced self-test kits, aided by digital health solutions and e-commerce, making home diagnostics more convenient. Nasal swab and saliva tests are preferred for their ease of use. Investment in multiplex diagnostics has surged, allowing for the detection of multiple respiratory viruses, thereby appealing to health agencies seeking cost-effective solutions. Additionally, AI-driven technologies have streamlined results, enhancing user confidence in both home and laboratory testing. Although market growth is expected, challenges persist from oversaturation and cost pressures, indicating a turbulent yet promising trajectory ahead for the testing kit sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global COVID Testing Kit market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global COVID Testing Kit Market Segments Analysis

Global COVID Testing Kit Market is segmented by Product Type, Specimen / Sample Type, End-User, Mode of Testing and region. Based on Product Type, the market is segmented into RT-PCR Assay Kits, Immunoassay Test Strips / Cassettes, CRISPR-Based Molecular Kits and Other Molecular Kits. Based on Specimen / Sample Type, the market is segmented into Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab, Saliva Sample and Blood / Finger-Prick. Based on End-User, the market is segmented into Hospitals & Clinics, Diagnostic Laboratories, Home Care / Self-Testing, Public Health Agencies and Others. Based on Mode of Testing, the market is segmented into Centralized Lab Testing (Non-POC), Point-of-Care (POC) Testing and Over-The-Counter (OTC) Self-Testing. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global COVID Testing Kit Market

A key market driver for the global COVID testing kit market is the rising emphasis on early detection and rapid response to infectious diseases. As public health authorities and governments worldwide prioritize strategies to control and prevent the spread of COVID-19, there is increased demand for reliable testing solutions. The growing awareness of asymptomatic cases and the need for accurate, timely diagnosis are propelling the adoption of various testing methods, including PCR and antigen tests. Furthermore, advancements in technology that enhance the accuracy and speed of testing processes continue to spur innovation and market growth, catering to both healthcare providers and the general public.

Restraints in the Global COVID Testing Kit Market

One key market restraint for the global COVID testing kit market is the saturation of available testing solutions, leading to increased competition among manufacturers. The rapid proliferation of at-home and point-of-care testing options has resulted in a fragmented market, causing price wars that can diminish profit margins for companies. Additionally, the evolving regulatory landscape and varying approval processes across regions can challenge consistent market entry for new products. Furthermore, public fatigue regarding testing and a decline in demand as vaccination rates rise may further restrict growth opportunities for manufacturers in this sector, making it crucial to innovate and diversify offerings.

Market Trends of the Global COVID Testing Kit Market

The global COVID testing kit market is experiencing a significant shift towards self-testing and home diagnostics, spurred by the demand for decentralized healthcare solutions. The advent of user-friendly, saliva-based antigen kits has gained traction among consumers, as they offer an affordable and convenient option for testing with reduced reliance on clinical settings, particularly amid recurring infection waves. Enhanced regulatory approvals have further supported this trend, leading to increased adoption of at-home testing solutions. This movement not only promotes consumer empowerment in health management but also reflects a broader transformation in healthcare delivery, shaping the future landscape of diagnostic testing.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape
• Customer & Buying Criteria Analysis
• Raw Material Analysis

Global COVID Testing Kit Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• RT-PCR Assay Kits
• Immunoassay Test Strips / Cassettes
• CRISPR-Based Molecular Kits
• Other Molecular Kits

Global COVID Testing Kit Market Size by Specimen / Sample Type & CAGR (2026-2033)

• Market Overview
• Nasopharyngeal Swab
• Oropharyngeal Swab
• Nasal Swab
• Saliva Sample
• Blood / Finger-Prick

Global COVID Testing Kit Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals & Clinics
• Diagnostic Laboratories
• Home Care / Self-Testing
• Public Health Agencies
• Others

Global COVID Testing Kit Market Size by Mode of Testing & CAGR (2026-2033)

• Market Overview
• Centralized Lab Testing (Non-POC)
• Point-of-Care (POC) Testing
• Over-The-Counter (OTC) Self-Testing

Global COVID Testing Kit Market Size & CAGR (2026-2033)

• North America (Product Type, Specimen / Sample Type, End-User, Mode of Testing)
  • US
  • Canada
• Europe (Product Type, Specimen / Sample Type, End-User, Mode of Testing)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Specimen / Sample Type, End-User, Mode of Testing)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Specimen / Sample Type, End-User, Mode of Testing)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Specimen / Sample Type, End-User, Mode of Testing)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quidel Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylab Discovery Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SD Biosensor
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seegene Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CEPI (Collaborative entities)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guangzhou Wondfo Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Bioeasy Biotechnology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 1drop Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ADT Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations